Dr. Michael Thomas
Claim this profileThoraxklinik-Heidelberg gGmbH
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
23 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
EGFR positive
2Lung Cancer
Stage III
Stage IV
EGFR positive
Affiliated Hospitals
Clinical Trials Michael Thomas is currently running
Ovaprene
for Birth Control
This trial is testing Ovaprene, a ring placed inside the vagina to prevent pregnancy without hormones. It aims to see how well it works, how safe it is, and if women find it acceptable. The study focuses on women who want a non-hormonal birth control option.
Recruiting1 award N/A13 criteria
Novel Immunotherapy Combinations
for Lung Cancer
This study will evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PDy) of novel immunotherapy combinations compared with immunotherapy monotherapy in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells \[TC\]/ Tumor proportion score \[TPS\] \>= 50%), previously untreated, unresectable, locally advanced or metastatic non-small cell lung cancer (NSCLC). Drug name mentioned as Belrestotug, GSK4428859A, and EOS884448 are all interchangeable for the same compound. In the rest of the document, the drug will be referred to as Belrestotug.
Recruiting1 award Phase 28 criteria
More about Michael Thomas
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Thomas has experience with
- Ipilimumab
- Niraparib
- Pembrolizumab
- Dostarlimab
- Ovaprene
- Nivolumab
Breakdown of trials Michael Thomas has run
Non-Small Cell Lung Cancer
Lung Cancer
Birth Control
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Thomas specialize in?
Michael Thomas focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Michael Thomas currently recruiting for clinical trials?
Yes, Michael Thomas is currently recruiting for 2 clinical trials in Heidelberg Baden-Wurttemberg. If you're interested in participating, you should apply.
Are there any treatments that Michael Thomas has studied deeply?
Yes, Michael Thomas has studied treatments such as Ipilimumab, Niraparib, Pembrolizumab.
What is the best way to schedule an appointment with Michael Thomas?
Apply for one of the trials that Michael Thomas is conducting.
What is the office address of Michael Thomas?
The office of Michael Thomas is located at: Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg 69126 Germany. This is the address for their practice at the Thoraxklinik-Heidelberg gGmbH.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.